Skip to main content
Thorax logoLink to Thorax
. 1996 May;51(5):537–539. doi: 10.1136/thx.51.5.537

Particle size selection device for use with the Turbohaler.

M L Everard 1, S G Devadason 1, P N Le Souef 1
PMCID: PMC473604  PMID: 8711685

Abstract

BACKGROUND: Drug deposited within the upper airways of patients using dry powder inhalers does not contribute to the therapeutic effect but can result in unwanted local side effects and, when swallowed, may contribute to systemic effects. A chamber has been devised which uses the centrifugal force generated by the Turbohaler to remove large "non-respirable" particles with a view to minimising deposition in the upper airway. An in vitro study was performed to determine whether such a chamber could reduce the dose contained in coarse particles without having a significant effect on the "respirable dose". METHODS: The mouthpiece of a 200 micrograms Turbohaler was modified to allow a small volume chamber to be attached. The particle size distribution generated by the Turbohaler was assessed using a multi-stage liquid impinger with a flow rate of 60 l/min. The quantity of drug on each stage was quantified using an ultraviolet spectrophotometric technique. For each experiment 10 actuations were used to ensure adequate quantities of drug on each stage. Particles depositing on stages 3 + 4 have a diameter of < 6.8 microns and are arbitrarily referred to as the "respirable dose". The particle size distribution obtained using the Turbohaler (n = 10) was compared with that from the Turbohaler+ chamber (n = 11). RESULTS: The addition of the chamber resulted in the mean (SD) dose contained in larger "non-respirable" particles depositing on stages 1 + 2 being reduced from 52.2 (12.3) to 29.6 (6.9) micrograms per actuation. However, the chamber did not affect the "respirable" dose. The dose contained in particles with a diameter of < 6.8 microns from the standard Turbohaler was 91.1 (8.9) micrograms compared with 82.4 (18.6) micrograms when used with the chamber. CONCLUSIONS: These results indicate that it is possible to devise an effective particle size selection device for the Turbohaler. It may be possible to produce such devices for other dry powder inhalers, although the design would need to be tailored to each particular device.

Full text

PDF
537

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Auty R. M., Brown K., Neale M. G., Snashall P. D. Respiratory tract deposition of sodium cromoglycate is highly dependent upon technique of inhalation using the Spinhaler. Br J Dis Chest. 1987 Oct;81(4):371–380. doi: 10.1016/0007-0971(87)90186-0. [DOI] [PubMed] [Google Scholar]
  2. Borgström L., Bondesson E., Morén F., Trofast E., Newman S. P. Lung deposition of budesonide inhaled via Turbuhaler: a comparison with terbutaline sulphate in normal subjects. Eur Respir J. 1994 Jan;7(1):69–73. doi: 10.1183/09031936.94.07010069. [DOI] [PubMed] [Google Scholar]
  3. Borgström L., Newman S., Weisz A., Morén F. Pulmonary deposition of inhaled terbutaline: comparison of scanning gamma camera and urinary excretion methods. J Pharm Sci. 1992 Aug;81(8):753–755. doi: 10.1002/jps.2600810807. [DOI] [PubMed] [Google Scholar]
  4. Engel T., Scharling B., Skovsted B., Heinig J. H. Effects, side effects and plasma concentrations of terbutaline in adult asthmatics after inhaling from a dry powder inhaler device at different inhalation flows and volumes. Br J Clin Pharmacol. 1992 Apr;33(4):439–444. doi: 10.1111/j.1365-2125.1992.tb04064.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Groth S., Dirksen H. Optimal inhalation procedure for the fenoterol powder inhaler. Eur J Respir Dis Suppl. 1983;130:17–24. [PubMed] [Google Scholar]
  6. Hansen O. R., Pedersen S. Optimal inhalation technique with terbutaline Turbuhaler. Eur Respir J. 1989 Jul;2(7):637–639. [PubMed] [Google Scholar]
  7. O'Callaghan C., Lynch J., Cant M., Robertson C. Improvement in sodium cromoglycate delivery from a spacer device by use of an antistatic lining, immediate inhalation, and avoiding multiple actuations of drug. Thorax. 1993 Jun;48(6):603–606. doi: 10.1136/thx.48.6.603. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Pedersen S., Hansen O. R., Fuglsang G. Influence of inspiratory flow rate upon the effect of a Turbuhaler. Arch Dis Child. 1990 Mar;65(3):308–310. doi: 10.1136/adc.65.3.308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Pedersen S. How to use a rotahaler. Arch Dis Child. 1986 Jan;61(1):11–14. doi: 10.1136/adc.61.1.11. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES